Citations

Citations to this article as recorded by  

• Clinical Phenotypes and Genetic Findings in Very-Early-Onset Inflammatory Bowel Disease: A Vietnamese Pediatric Cohort Study
  Manh Cuong Nguyen, Thi Viet Ha Nguyen, Loi Nguyen, Thuy Ha Dang, Tam Tran, Thi Van Anh Nguyen, Ngoc Thach Hoang, Ngoc Quynh Le Nguyen, Thi Minh Phuong Do, Van Tinh Nguyen, Hai Yen Vu, Thi Ngoc Hong Nguyen, Thi Thu Trang Nguyen, Thi Cam Van Le, Thi Khanh N
  Children.2026; 13(5): 666.     CrossRef

Citations

Citations to this article as recorded by  

• Diet in Inflammatory Bowel Diseases: Efficacy, Tolerability, and Microbiome Effects Toward Personalized Management
  Francesco Calabrese, Andrea Pasta, Elena Formisano, Elisa Marabotto, Manuele Furnari, Livia Pisciotta, Patrizia Zentilin, Edoardo G. Giannini, Giorgia Bodini
  Digestive Diseases and Sciences.2026; 71(5): 1650.     CrossRef
• Crohnʼs Disease Exclusion Diet (CDED) und partielle enterale Ernährungstherapie (PEN) zur Remissionsinduktion bei Kindern und Jugendlichen mit Morbus Crohn – Aktualisierte Stellungnahme der Arbeitsgemeinschaften CEDATA und Ernährung/Diätetik/Ernährungsmed
  Evdokia Alexanidou, André Hörning, Jan de Laffolie, Anjona Schmidt-Choudhury, Jan Däbritz, AG Ernährung und CEDATA-Studiengruppe
  Zeitschrift für Gastroenterologie.2026; 64(02): 184.     CrossRef
• Adjunct polymeric exclusive enteral nutrition helps achieve biochemical remission in active Crohn’s disease in adults irrespective of disease location and concomitant corticosteroid use
  Hellen Kuo, Katrina Tognolini, Rumbidzai Mutsekwa, Dheeraj Shukla, Laura Willmann, Hadi Moattar, Alexander Dorrington, Naveed Ishaq, Maneesha Bhullar, John Edwards, Waled Mohsen, Pradeep Kakkadasam Ramaswamy
  Frontline Gastroenterology.2025; 16(1): 3.     CrossRef
• Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis
  Aleksandra Jatkowska, Bernadette White, Konstantinos Gkikas, John Paul Seenan, Jonathan MacDonald, Konstantinos Gerasimidis
  Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
• Positionspapier der Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) zum zulassungsüberschreitenden Gebrauch von für Erwachsene mit CED zugelassenen Biologika und Signalinhibitoren bei Kindern und Jugendlichen
  Jan Däbritz, Martin Classen, Kathrin Krohn, Andreas Krahl, Stephan Buderus, Elke Lainka, Jan de Laffolie, Carsten Posovszky
  Zeitschrift für Gastroenterologie.2025; 63(03): 255.     CrossRef
• Understanding Role of Nutrition in Inflammatory Bowel Disease: A Comprehensive Review With Incorporation of AGA Update
  Galvin Dhaliwal, Dushyant Singh Dahiya, Ashvin Singh Dhaliwal, Hassam Ali, Manesh Kumar Gangwani, Fouad Jaber, Saqr Alsakarneh, Islam Mohamed, Umar Hayat, Bhanu Siva Mohan Pinnam, Sahib Singh, Sasha Mangray, Stephen Bickston
  Journal of Gastroenterology and Hepatology.2025; 40(6): 1352.     CrossRef
• TPMT and HLA-DQ Allelic Variants in Relation to Drug Response, Safety and Need for Therapy Optimization in Pediatric Inflammatory Bowel Disease
  Mirjana Stojšić, Ognjen Ležakov, Sanja Ćeranić, Nikola Stojšić, Marko Rajković, Savina Marković, Milica Kovačević, Nina Brkić
  Children.2025; 12(10): 1334.     CrossRef
• Human Gut Microbiome in Relation to Food, Nutrition, Health and Disease
  Mirjana Menkovska, Sabeen Raza
  Advances in Bioscience and Biotechnology.2025; 16(12): 550.     CrossRef
• From the gut to the brain: Potential novel avenues for IBD treatment via serotonergic pathways
  Sara Ibgui, Daisy Lints, Simon Milling
  Pharmacological Research.2025; 222: 108059.     CrossRef
• Mycobacterium avium ssp. paratuberculosis and Crohn’s Disease—Diagnostic Microbiological Investigations Can Inform New Therapeutic Approaches
  John M. Aitken, Jack E. Aitken, Gaurav Agrawal
  Antibiotics.2024; 13(2): 158.     CrossRef
• Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline
  Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignass, Robert Ehehalt, Christoph-Thomas Germer, P. C. Grunert, Ulf Helwig, Karoline Horisberger, Klaus Herrlinger, Peter Kienle, Torsten Kucharzik, Jost Langhorst, Christian Maaser,
  Zeitschrift für Gastroenterologie.2024; 62(08): 1229.     CrossRef
• Mechanisms of Action of Exclusive Enteral Nutrition and Other Nutritional Therapies in Crohn’s Disease
  Ramasatyaveni Geesala, Pratik Gongloor, Neeraja Recharla, Xuan-Zheng Shi
  Nutrients.2024; 16(21): 3581.     CrossRef
• Is Salt at Fault? Dietary Salt Consumption and Inflammatory Bowel Disease
  Rebecca Kuang, Stephen J D O’Keefe, Claudia Ramos del Aguila de Rivers, Filippos Koutroumpakis, David G Binion
  Inflammatory Bowel Diseases.2023; 29(1): 140.     CrossRef
• The Role of the Gut Microbiota in the Relationship Between Diet and Human Health
  Bryce K. Perler, Elliot S. Friedman, Gary D. Wu
  Annual Review of Physiology.2023; 85(1): 449.     CrossRef
• Global research trends on diet and nutrition in Crohn’s disease
  Muna Shakhshir, Sa'ed H Zyoud
  World Journal of Gastroenterology.2023; 29(20): 3203.     CrossRef
• Enterale Ernährungstherapien beim pädiatrischen M. Crohn Anwendungen und Wirkweise
  André Hörning, Anjona Schmidt-Choudhury
  Aktuelle Ernährungsmedizin.2023; 48(03): 183.     CrossRef
• Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter
  Nikolas Dovrolis, Anastasia Moschoviti, Smaragdi Fessatou, George Karamanolis, George Kolios, Maria Gazouli
  Biomedicines.2023; 11(7): 1979.     CrossRef
• Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases
  Hala Elzayat, Ghaidaa Mesto, Farah Al-Marzooq
  Nutrients.2023; 15(15): 3377.     CrossRef
• Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
  Catherine O’Reilly, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, R. Paul Ross
  Microbiome Research Reports.2023;[Epub]     CrossRef
• Current understanding of the aetiology and pathogenesis of inflammatory bowel diseases (Part 2): the role of the microbiome and nutritional factors
  A. I. Khavkin, K. M. Nikolaychuk, E. V. Shrayner, D. R. Shaimardanova, A. S. Veremenko, I. D. Levchenko, P. Ya. Platonova, M. F. Novikova, V. V. Dudurich
  Experimental and Clinical Gastroenterology.2023; (12): 164.     CrossRef
• FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence
  Catarina D. Simões, Marta Maganinho, Ana S. Sousa
  European Journal of Nutrition.2022; 61(3): 1187.     CrossRef
• Effects of Olive Oil and Its Components on Intestinal Inflammation and Inflammatory Bowel Disease
  Josip Vrdoljak, Marko Kumric, Marino Vilovic, Dinko Martinovic, Iris Jeroncic Tomic, Mladen Krnic, Tina Ticinovic Kurir, Josko Bozic
  Nutrients.2022; 14(4): 757.     CrossRef
• Exclusive enteral nutrition: An optimal care pathway for use in children with active luminal Crohn's disease
  Deirdre Burgess, Kathleen H McGrath, Caitlin Watson, Tanya Collins, Stephanie Brown, Katie Marks, Kate Dehlsen, Kim Herbison, Emma Landorf, Laura Benn, Julia Fox, Ming Liew
  Journal of Paediatrics and Child Health.2022; 58(4): 572.     CrossRef
• Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004
  Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Oc
  Zeitschrift für Gastroenterologie.2022; 60(03): 332.     CrossRef
• The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
  Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos
  Journal of Clinical Medicine.2022; 11(11): 3045.     CrossRef
• Laser Therapy in Perianal Fistulas
  Mircea Sandor, Maur Sebastian Horgos, Ioan Lucian Borza, Rodica Negrean, Mihai Botea, Szuhai Erika Bimbo, Anca Huniadi, Liliana Sachelarie, Loredana Liliana Hurjui, Irina Mihaela Jemnoschi Hreniuc
  Applied Sciences.2022; 12(23): 12433.     CrossRef
• Enterale Ernährungstherapien beim pädiatrischen M. Crohn
  André Hörning, Anjona Schmidt-Choudhury
  Kinder- und Jugendmedizin.2022; 22(06): 439.     CrossRef
• Dietary patterns, beliefs and behaviours among individuals with inflammatory bowel disease: a cross‐sectional study
  K. J. Kamp, B. Pennings, D. Javelli, G. Wyatt, B. Given
  Journal of Human Nutrition and Dietetics.2021; 34(2): 257.     CrossRef
• Alterations in drug disposition in older adults: a focus on geriatric syndromes
  Dorsa Maher, Nagham Ailabouni, Arduino A. Mangoni, Michael D. Wiese, Emily Reeve
  Expert Opinion on Drug Metabolism & Toxicology.2021; 17(1): 41.     CrossRef
• Nutritional Therapy Strategies in Pediatric Crohn’s Disease
  Charlotte M. Verburgt, Mohammed Ghiboub, Marc A. Benninga, Wouter J. de Jonge, Johan E. Van Limbergen
  Nutrients.2021; 13(1): 212.     CrossRef
• Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice
  Fuzheng Tao, Xi Xing, Jiannong Wu, Ronglin Jiang, Tamil Selvan Anthonymuthu
  PLOS ONE.2021; 16(3): e0248482.     CrossRef
• Fish Sidestream-Derived Protein Hydrolysates Suppress DSS-Induced Colitis by Modulating Intestinal Inflammation in Mice
  Maria G. Daskalaki, Konstantinos Axarlis, Tone Aspevik, Michail Orfanakis, Ourania Kolliniati, Ioanna Lapi, Maria Tzardi, Eirini Dermitzaki, Maria Venihaki, Katerina Kousoulaki, Christos Tsatsanis
  Marine Drugs.2021; 19(6): 312.     CrossRef
• Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
  Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
  Intestinal Research.2021; 19(3): 291.     CrossRef
• Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea
  Hyun Jin Kim, Seak Hee Oh, Sung Hee Lee, Yu-Bin Kim, Dae Yeon Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Kyung Mo Kim
  Gut and Liver.2021; 15(6): 851.     CrossRef
• The Effect of Formula-based Nutritional Treatment on Colitis in a Murine Model
  Sooyoung Jang, Younjuong Kim, Changjun Lee, Bomi Kwon, Jihye Noh, Jai J. Jee, Sang Sun Yoon, Hong Koh, Sowon Park
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn’s Disease
  Luís Rodrigues, Sofia Moeda, Helena Loreto, Sara Azevedo, Inês Asseiceira, Catarina Maltez, Ana Fernandes, Ana Paula Mourato, Ana Isabel Lopes
  Nutrición Clínica y Dietética Hospitalaria.2021;[Epub]     CrossRef